Mitsui Chemicals Inc. (TYO:4183) plans to get back involved in the CDMO business for nucleic acid drugs. By 2025, the…...
Please subscribe to read the full story.
nucleic acid drugs
NOF to Invest Big in DDS Materials in Anticipation of Growing Nucleic Acid Drug Market
NOF Corp. (TYO:4403) plans to invest more than 10 billion yen ($87.49 million) by fiscal 2025 in its drug delivery…...
Please subscribe to read the full story.
Sumitomo Chemical Eyes Mass Production of Nucleic Acid Drug Substance for Genome Editing
Sumitomo Chemical Co. Ltd. (TYO:4005) is looking to establish a new plant for the mass production of single-guide RNA, a…...
Please subscribe to read the full story.
